| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| PAVMPAVmed Inc. | 8.06M | 8.75 | 17.64 | 22.15% | -217914.55% | -245.07% | ||
| SMLRSemler Scientific, Inc. | 310.75M | 20.33 | 3.96 | -17.44% | 130.8% | 10.51% | 0.00 | |
| BJDXBluejay Diagnostics, Inc. | 1.18M | 0.65 | -0.02 | -185.51% | 0.04 | |||
| HSCSHeartSciences Inc. | 10.17M | 3.20 | -0.34 | -76.61% | -1042.38% | -216.05% | 14.55 | |
| LUCDLucid Diagnostics Inc. | 163.87M | 1.25 | -1.19 | 79% | -8.6% | -404.1% | 3.94 | |
| BMRABiomerica, Inc. | 8.09M | 2.68 | -1.24 | -1.92% | -90.29% | -90.76% | 0.11 | |
| MDAISpectral AI, Inc. | 49.41M | 1.61 | -1.89 | 63.83% | -70.64% | |||
| CODXCo-Diagnostics, Inc. | 6.12M | 2.92 | -2.35 | -42.53% | -63.36% | -80.8% | 0.04 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 36.14M | 64.07M | 99.13M | 147.28M | 214.55M | 265.17M | 322.82M | 410.92M | 492.68M | 591.84M |
| Revenue Growth % | 0.66% | 0.77% | 0.55% | 0.49% | 0.46% | 0.24% | 0.22% | 0.27% | 0.2% | 0.2% |
| Cost of Goods Sold | 14.7M | 20.88M | 28.2M | 38.8M | 52.48M | 70.28M | 109.26M | 129.29M | 160.88M | 184.31M |
| COGS % of Revenue | 0.41% | 0.33% | 0.28% | 0.26% | 0.24% | 0.27% | 0.34% | 0.31% | 0.33% | 0.31% |
| Gross Profit | 21.44M | 43.19M | 70.93M | 108.48M | 162.07M | 194.89M | 213.57M | 281.63M | 331.81M | 407.53M |
| Gross Margin % | 0.59% | 0.67% | 0.72% | 0.74% | 0.76% | 0.73% | 0.66% | 0.69% | 0.67% | 0.69% |
| Gross Profit Growth % | 0.92% | 1.01% | 0.64% | 0.53% | 0.49% | 0.2% | 0.1% | 0.32% | 0.18% | 0.23% |
| Operating Expenses | 43.07M | 58.77M | 98.52M | 154.17M | 216.82M | 238.56M | 313.51M | 395.42M | 456.97M | 523.04M |
| OpEx % of Revenue | 1.19% | 0.92% | 0.99% | 1.05% | 1.01% | 0.9% | 0.97% | 0.96% | 0.93% | 0.88% |
| Selling, General & Admin | 36.72M | 51.62M | 85.25M | 133.31M | 179.52M | 197.23M | 274.84M | 322.2M | 385.64M | 418.56M |
| SG&A % of Revenue | 1.02% | 0.81% | 0.86% | 0.91% | 0.84% | 0.74% | 0.85% | 0.78% | 0.78% | 0.71% |
| Research & Development | 6.35M | 7.15M | 13.27M | 20.86M | 37.3M | 41.33M | 38.67M | 46.61M | 60.24M | 103.83M |
| R&D % of Revenue | 0.18% | 0.11% | 0.13% | 0.14% | 0.17% | 0.16% | 0.12% | 0.11% | 0.12% | 0.18% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26.61M | 11.08M | 641K |
| Operating Income | -21.63M | -15.58M | -27.59M | -45.69M | -54.76M | -43.67M | -99.94M | -113.78M | -125.16M | -115.5M |
| Operating Margin % | -0.6% | -0.24% | -0.28% | -0.31% | -0.26% | -0.16% | -0.31% | -0.28% | -0.25% | -0.2% |
| Operating Income Growth % | -0.47% | 0.28% | -0.77% | -0.66% | -0.2% | 0.2% | -1.29% | -0.14% | -0.1% | 0.08% |
| EBITDA | -21.14M | -15.01M | -25.99M | -43.42M | -51.31M | -30.74M | -83.35M | -94.17M | -103.02M | -89.73M |
| EBITDA Margin % | -0.58% | -0.23% | -0.26% | -0.29% | -0.24% | -0.12% | -0.26% | -0.23% | -0.21% | -0.15% |
| EBITDA Growth % | -0.46% | 0.29% | -0.73% | -0.67% | -0.18% | 0.4% | -1.71% | -0.13% | -0.09% | 0.13% |
| D&A (Non-Cash Add-back) | 492K | 568K | 1.6M | 2.27M | 3.44M | 12.93M | 16.59M | 19.61M | 22.14M | 25.78M |
| EBIT | -21.74M | -17.66M | -26.35M | -47.22M | -52.86M | -42.08M | -99.83M | -111.75M | -119.01M | -99.9M |
| Net Interest Income | -1.06M | -3.25M | -3.39M | -3.12M | -1.64M | -1.52M | -1.05M | -1.79M | 2.5M | 9.12M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 118K | 2.35M | 6.16M | 21.94M |
| Interest Expense | 1.06M | 3.25M | 3.39M | 3.12M | 1.64M | 1.52M | 1.17M | 4.14M | 3.65M | 12.82M |
| Other Income/Expense | -1.17M | -5.32M | -2.15M | -4.64M | 252K | 72K | -1.05M | -2.1M | 2.5M | 2.78M |
| Pretax Income | -22.8M | -20.9M | -29.74M | -50.33M | -54.5M | -43.6M | -100.99M | -115.89M | -122.66M | -112.72M |
| Pretax Margin % | -0.63% | -0.33% | -0.3% | -0.34% | -0.25% | -0.16% | -0.31% | -0.28% | -0.25% | -0.19% |
| Income Tax | 0 | 0 | 0 | 44K | 65K | 229K | 367K | 269K | 750K | 565K |
| Effective Tax Rate % | 1% | 1% | 1% | 1% | 1% | 1.01% | 1% | 1% | 1.01% | 1.01% |
| Net Income | -22.8M | -20.9M | -29.74M | -50.38M | -54.57M | -43.83M | -101.36M | -116.16M | -123.41M | -113.29M |
| Net Margin % | -0.63% | -0.33% | -0.3% | -0.34% | -0.25% | -0.17% | -0.31% | -0.28% | -0.25% | -0.19% |
| Net Income Growth % | -0.44% | 0.08% | -0.42% | -0.69% | -0.08% | 0.2% | -1.31% | -0.15% | -0.06% | 0.08% |
| Net Income (Continuing) | -22.8M | -20.9M | -29.74M | -50.38M | -54.57M | -43.83M | -101.36M | -116.16M | -123.41M | -113.29M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.54 | -3.95 | -1.30 | -2.02 | -2.16 | -1.58 | -3.46 | -3.88 | -4.04 | -3.63 |
| EPS Growth % | -0.44% | -1.56% | 0.67% | -0.55% | -0.07% | 0.27% | -1.19% | -0.12% | -0.04% | 0.1% |
| EPS (Basic) | -1.54 | -3.95 | -1.30 | -2.02 | -2.16 | -1.58 | -3.46 | -3.88 | -4.04 | -3.63 |
| Diluted Shares Outstanding | 14.77M | 5.29M | 22.63M | 23.89M | 25.27M | 27.75M | 29.33M | 29.92M | 30.53M | 31.2M |
| Basic Shares Outstanding | 14.77M | 5.29M | 22.63M | 23.89M | 25.27M | 27.75M | 29.33M | 29.92M | 30.53M | 31.2M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 32.83M | 118.61M | 119.58M | 106.48M | 172.79M | 377.82M | 305.52M | 288.77M | 230.81M | 645.82M |
| Cash & Short-Term Investments | 25.21M | 106.05M | 102.36M | 78.34M | 140.55M | 335.22M | 239.13M | 213.14M | 133.76M | 535.55M |
| Cash Only | 25.21M | 51.64M | 8.67M | 20.02M | 20.46M | 88.63M | 127.56M | 78.83M | 36.17M | 419.6M |
| Short-Term Investments | 0 | 54.41M | 93.69M | 58.32M | 120.09M | 246.59M | 111.57M | 134.31M | 97.59M | 115.96M |
| Accounts Receivable | 5.58M | 9.41M | 12.95M | 19.79M | 23.87M | 29.93M | 46.43M | 49.92M | 61.48M | 79.94M |
| Days Sales Outstanding | 56.33 | 53.58 | 47.69 | 49.05 | 40.6 | 41.2 | 52.5 | 44.34 | 45.55 | 49.3 |
| Inventory | 1.15M | 1.39M | 1.68M | 2.06M | 4.04M | 5.31M | 10.27M | 15.15M | 13.97M | 14.04M |
| Days Inventory Outstanding | 28.43 | 24.29 | 21.78 | 19.4 | 28.07 | 27.59 | 34.3 | 42.78 | 31.7 | 27.8 |
| Other Current Assets | 91K | 91K | 2.58M | 4.1M | 4.34M | 7.36M | 9.69M | 10.55M | 21.59M | 16.29M |
| Total Non-Current Assets | 5.04M | 19.55M | 13.54M | 13.23M | 133.42M | 133.91M | 157.44M | 159.45M | 202.33M | 285.63M |
| Property, Plant & Equipment | 2.04M | 4.65M | 6.22M | 9.16M | 116.59M | 118.96M | 140.53M | 136.34M | 153.43M | 172.66M |
| Fixed Asset Turnover | 17.75x | 13.77x | 15.93x | 16.08x | 1.84x | 2.23x | 2.30x | 3.01x | 3.21x | 3.43x |
| Goodwill | 862K | 862K | 862K | 862K | 862K | 862K | 862K | 862K | 862K | 862K |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 10.98M | 2.99M | 0 | 8.03M | 0 | 0 | 0 | 3M | 61.9M |
| Other Non-Current Assets | 2.15M | 3.05M | 3.46M | 3.21M | 7.94M | 14.09M | 16.05M | 22.25M | 45.04M | 50.21M |
| Total Assets | 37.87M | 138.16M | 133.12M | 119.71M | 306.21M | 511.74M | 462.97M | 448.22M | 433.14M | 931.45M |
| Asset Turnover | 0.95x | 0.46x | 0.74x | 1.23x | 0.70x | 0.52x | 0.70x | 0.92x | 1.14x | 0.64x |
| Asset Growth % | 1.05% | 2.65% | -0.04% | -0.1% | 1.56% | 0.67% | -0.1% | -0.03% | -0.03% | 1.15% |
| Total Current Liabilities | 8.78M | 13.21M | 20.92M | 30.24M | 52.07M | 65.67M | 87.85M | 89.1M | 107.37M | 110.92M |
| Accounts Payable | 1.46M | 2.1M | 2.4M | 2.28M | 8.24M | 4.37M | 10.51M | 7.52M | 5.54M | 7.22M |
| Days Payables Outstanding | 36.23 | 36.76 | 31 | 21.49 | 57.32 | 22.67 | 35.11 | 21.22 | 12.58 | 14.3 |
| Short-Term Debt | 0 | 0 | 1.49M | 0 | 1.94M | 11.67M | 11.67M | 0 | 0 | 0 |
| Deferred Revenue (Current) | 506K | 947K | 1000K | 1000K | 1000K | 930K | 1000K | 1000K | 1000K | 1000K |
| Other Current Liabilities | 0 | 257K | 1.38M | 5.81M | 9.75M | 13.96M | 8.57M | 18.7M | 1.04M | 35.11M |
| Current Ratio | 3.74x | 8.98x | 5.72x | 3.52x | 3.32x | 5.75x | 3.48x | 3.24x | 2.15x | 5.82x |
| Quick Ratio | 3.61x | 8.87x | 5.64x | 3.45x | 3.24x | 5.67x | 3.36x | 3.07x | 2.02x | 5.70x |
| Cash Conversion Cycle | 48.53 | 41.12 | 38.48 | 46.96 | 11.35 | 46.12 | 51.69 | 65.9 | 64.68 | 62.8 |
| Total Non-Current Liabilities | 130.72M | 32.38M | 32.65M | 35.05M | 118.74M | 104.46M | 95.6M | 119.31M | 115.68M | 729.62M |
| Long-Term Debt | 30.55M | 32.23M | 32.49M | 34.9M | 32.99M | 21.34M | 9.69M | 34.94M | 34.95M | 646.44M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 85.75M | 81.29M | 85.21M | 83.07M | 79.72M | 74.6M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 100.17M | 152K | 161K | 153K | 0 | 1.83M | 697K | 1.31M | 1.01M | 8.58M |
| Total Liabilities | 139.5M | 45.59M | 53.57M | 65.29M | 170.8M | 170.13M | 183.45M | 208.41M | 223.05M | 840.54M |
| Total Debt | 30.55M | 32.23M | 33.98M | 34.9M | 128.59M | 122.47M | 117.71M | 131.04M | 129.82M | 736.91M |
| Net Debt | 5.34M | -19.42M | 25.31M | 14.88M | 108.13M | 33.84M | -9.85M | 52.21M | 93.65M | 317.31M |
| Debt / Equity | - | 0.35x | 0.43x | 0.64x | 0.95x | 0.36x | 0.42x | 0.55x | 0.62x | 8.11x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -20.43x | -4.80x | -8.15x | -14.67x | -33.33x | -28.75x | -85.49x | -27.50x | -34.29x | -9.01x |
| Total Equity | -101.62M | 92.56M | 79.55M | 54.42M | 135.41M | 341.61M | 279.51M | 239.81M | 210.1M | 90.91M |
| Equity Growth % | -14.99% | 1.91% | -0.14% | -0.32% | 1.49% | 1.52% | -0.18% | -0.14% | -0.12% | -0.57% |
| Book Value per Share | -6.88 | 17.51 | 3.52 | 2.28 | 5.36 | 12.31 | 9.53 | 8.02 | 6.88 | 2.91 |
| Total Shareholders' Equity | -101.62M | 92.56M | 79.55M | 54.42M | 135.41M | 341.61M | 279.51M | 239.81M | 210.1M | 90.91M |
| Common Stock | 1K | 22K | 23K | 23K | 25K | 27K | 27K | 28K | 31K | 31K |
| Retained Earnings | -106.27M | -127.17M | -156.59M | -203.51M | -260.39M | -304.68M | -406.05M | -522.2M | -645.61M | -758.89M |
| Treasury Stock | -4.64M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -25M |
| Accumulated OCI | -1.08M | -9K | -65K | -41K | 82K | 11K | -61K | -396K | -112K | 165K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -18M | -16.65M | -14.91M | -29.07M | -21.86M | -13.76M | -37.75M | -23.01M | -50.1M | 3.39M |
| Operating CF Margin % | -0.5% | -0.26% | -0.15% | -0.2% | -0.1% | -0.05% | -0.12% | -0.06% | -0.1% | 0.01% |
| Operating CF Growth % | -0.15% | 0.08% | 0.1% | -0.95% | 0.25% | 0.37% | -1.74% | 0.39% | -1.18% | 1.07% |
| Net Income | -22.8M | -20.9M | -29.42M | -48.28M | -54.57M | -43.83M | -101.36M | -116.16M | -123.41M | 0 |
| Depreciation & Amortization | 492K | 568K | 1.6M | 2.27M | 3.44M | 6.9M | 16.59M | 19.61M | 22.14M | 0 |
| Stock-Based Compensation | 1.41M | 1.87M | 10.12M | 16.33M | 26.24M | 41.52M | 0 | 57.74M | 77.2M | 0 |
| Deferred Taxes | 10K | 4.69M | 9.06M | 17.41M | 23.76M | 31.86M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 227K | 3.85M | 1.81M | -2.93M | 8.99M | 6.03M | 93.24M | 81.3M | 76M | 102.51M |
| Working Capital Changes | 2.65M | -6.73M | -8.08M | -13.87M | -29.73M | -56.23M | -46.23M | -65.51M | -102.05M | -99.12M |
| Change in Receivables | -626K | -8.52M | -12.95M | -22.89M | -28.73M | -37.96M | -53.57M | -61.84M | -81.19M | -91.92M |
| Change in Inventory | -327K | -245K | -293K | -380K | -1.97M | -1.39M | -4.96M | -5.11M | 979K | -224K |
| Change in Payables | 132K | 305K | 634K | -192K | 5.6M | -3.88M | 6.13M | -2.99M | -1.97M | -7.41M |
| Cash from Investing | -1.79M | -68.17M | -34.59M | 34.12M | -89.27M | -132.39M | 105.26M | -52.43M | -1.21M | -122.98M |
| Capital Expenditures | -1.79M | -2.76M | -3.56M | -5.18M | -20.46M | -13.55M | -28.07M | -29.83M | -40.42M | -33.94M |
| CapEx % of Revenue | 0.05% | 0.04% | 0.04% | 0.04% | 0.1% | 0.05% | 0.09% | 0.07% | 0.08% | 0.06% |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -65.4M | 91K | 39.32M | -68.82M | -118.84M | 0 | 0 | 0 | -89.04M |
| Cash from Financing | 36.38M | 111.25M | 6.53M | 6.3M | 111.58M | 214.32M | -28.58M | 26.72M | 8.82M | 511.38M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | 12.27M | -3.18M | 142K | 2.8M | 4.21M | 10.23M | -25.85M | 13.18M | 8.82M | -83.46M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -19.79M | -19.41M | -18.47M | -34.25M | -42.32M | -27.31M | -65.82M | -52.84M | -90.53M | -30.55M |
| FCF Margin % | -0.55% | -0.3% | -0.19% | -0.23% | -0.2% | -0.1% | -0.2% | -0.13% | -0.18% | -0.05% |
| FCF Growth % | -0.22% | 0.02% | 0.05% | -0.85% | -0.24% | 0.35% | -1.41% | 0.2% | -0.71% | 0.66% |
| FCF per Share | -1.34 | -3.67 | -0.82 | -1.43 | -1.67 | -0.98 | -2.24 | -1.77 | -2.97 | -0.98 |
| FCF Conversion (FCF/Net Income) | 0.79x | 0.80x | 0.50x | 0.58x | 0.40x | 0.31x | 0.37x | 0.20x | 0.41x | -0.03x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.32M | 2.96M | 6.39M |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 287K | 1.13M | 923K |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | -22.58% | -34.56% | -75.21% | -57.49% | -18.38% | -32.64% | -44.73% | -54.86% | -75.27% |
| Return on Invested Capital (ROIC) | - | - | -23.25% | -39.35% | -26.25% | -10.58% | -23.24% | -30.39% | -31.51% | -24.34% |
| Gross Margin | 59.32% | 67.41% | 71.55% | 73.66% | 75.54% | 73.5% | 66.16% | 68.54% | 67.35% | 68.86% |
| Net Margin | -63.09% | -32.62% | -30% | -34.21% | -25.43% | -16.53% | -31.4% | -28.27% | -25.05% | -19.14% |
| Debt / Equity | - | 0.35x | 0.43x | 0.64x | 0.95x | 0.36x | 0.42x | 0.55x | 0.62x | 8.11x |
| Interest Coverage | -20.43x | -4.80x | -8.15x | -14.67x | -33.33x | -28.75x | -85.49x | -27.50x | -34.29x | -9.01x |
| FCF Conversion | 0.79x | 0.80x | 0.50x | 0.58x | 0.40x | 0.31x | 0.37x | 0.20x | 0.41x | -0.03x |
| Revenue Growth | 66.17% | 77.29% | 54.72% | 48.57% | 45.68% | 23.59% | 21.74% | 27.29% | 19.9% | 20.13% |
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Commercial Payors | 69.36M | - | 135.94M | 193.87M | 223.98M | 267.19M | 311.61M |
| Commercial Payors Growth | - | - | - | 42.62% | 15.53% | 19.29% | 16.62% |
| Centers For Medicare And Medicaid | 40.55M | 58.92M | 72.54M | 44.53M | 103.03M | 122.41M | 142.39M |
| Centers For Medicare And Medicaid Growth | - | 45.29% | 23.11% | -38.61% | 131.38% | 18.81% | 16.32% |
| Healthcare Institutions | 37.38M | 43.02M | 41.4M | 57.5M | 59.77M | 71M | 95.11M |
| Healthcare Institutions Growth | - | 15.09% | -3.77% | 38.89% | 3.96% | 18.79% | 33.96% |
| Non-contracted Third-party Payors | - | 10.77M | 15.29M | 26.93M | 24.13M | 32.07M | 42.73M |
| Non-contracted Third-party Payors Growth | - | - | 42.01% | 76.06% | -10.38% | 32.89% | 33.24% |
iRhythm Technologies, Inc. (IRTC) reported $702.6M in revenue for fiscal year 2024. This represents a 4472% increase from $15.4M in 2013.
iRhythm Technologies, Inc. (IRTC) grew revenue by 20.1% over the past year. This is strong growth.
iRhythm Technologies, Inc. (IRTC) reported a net loss of $51.5M for fiscal year 2024.
iRhythm Technologies, Inc. (IRTC) has a return on equity (ROE) of -75.3%. Negative ROE indicates the company is unprofitable.
iRhythm Technologies, Inc. (IRTC) generated $32.4M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.